Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.
Jiang Q, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B, Jiang H, Chen H, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Lai YY, Huang XJ.
Jiang Q, et al. Among authors: wang y.
Blood. 2011 Mar 17;117(11):3032-40. doi: 10.1182/blood-2010-09-308510. Epub 2011 Jan 20.
Blood. 2011.
PMID: 21252092
Free article.
Clinical Trial.